<SEC-DOCUMENT>0000950170-24-097108.txt : 20240814
<SEC-HEADER>0000950170-24-097108.hdr.sgml : 20240814
<ACCEPTANCE-DATETIME>20240814164008
ACCESSION NUMBER:		0000950170-24-097108
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20240814
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240814
DATE AS OF CHANGE:		20240814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HCW Biologics Inc.
		CENTRAL INDEX KEY:			0001828673
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				825024477
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40591
		FILM NUMBER:		241208890

	BUSINESS ADDRESS:	
		STREET 1:		2929 N COMMERCE PKWY
		CITY:			MIRAMAR
		STATE:			FL
		ZIP:			33025
		BUSINESS PHONE:		954-842-2024

	MAIL ADDRESS:	
		STREET 1:		2929 N COMMERCE PKWY
		CITY:			MIRAMAR
		STATE:			FL
		ZIP:			33025
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hcwb-20240814.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-08-14T12:28:40.7706+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:hcwb="http://hcwbiologics.com/20240814" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_f4f147cd-fe09-42a0-9093-fe59ada1fe2d" name="dei:AmendmentFlag" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d">false</ix:nonNumeric><ix:nonNumeric id="F_4b031ab4-97cb-4beb-9515-5f9db386250e" name="dei:EntityCentralIndexKey" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d">0001828673</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="hcwb-20240814.xsd"/></ix:references><ix:resources><xbrli:context id="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001828673</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-14</xbrli:startDate><xbrli:endDate>2024-08-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="min-height:0.5in;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bd02c29f-ee1b-4440-b149-6ed98b85a7f3" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_f14da008-21d3-4f23-8ab9-7aa1975fdcf0" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">August 14, 2024</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8c4f915f-5240-4751-a751-7e317eef37ab" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">HCW Biologics Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;"/>
    <td style="width:1%;"/>
    <td style="width:20%;"/>
    <td style="width:18%;"/>
    <td style="width:41%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_335add76-7590-4243-86b5-0083d73165e1" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_bbd41bde-d871-41ff-95c3-5c112780d1a0" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">001-40591</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d789c665-7eff-4a51-93ce-545bce87df43" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">82-5024477</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_59f4c9ec-684b-428c-9579-40c21be17d01" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2929 N. Commerce Parkway</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_84ca2f67-6a13-4fb5-b106-08e6fa408061" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Miramar</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_d905d941-916a-45b3-8d88-ce81a78f120a" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Florida</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_24285dc6-ee82-410c-9340-49aaf645da18" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">33025</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_f9c4f0d2-6efa-4401-a6ac-75bc9bd0b25a" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">954</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_e84430c1-7605-468d-9e1e-42d6da1d5236" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">842-2024</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9338418e-7a1f-4c30-8725-70067f97b57d" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityInformationFormerLegalOrRegisteredName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Not Applicable</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f5a46b62-1ec3-45a2-8154-47bf5db44ecd" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_58c30669-9222-4d4b-83e3-93ba210e94e3" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_157e875f-a13a-47c4-8947-ff3fa58ac824" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_552b8d6d-df76-40b8-8b49-af0412ec6d83" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;"/>
    <td style="width:1%;"/>
    <td style="width:15%;"/>
    <td style="width:1%;"/>
    <td style="width:45%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_48a7d99d-7bcd-4f05-ae94-5847a99c1399" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e2cd2054-4337-4b2b-8afd-712f88af8534" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">HCWB</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0fde23ac-f201-4b86-9f61-3a1f5f1a6e75" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_9bfbc21a-c294-4387-bc36-073a2423c1b9" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;"><ix:nonNumeric id="F_cfe9e9cf-ba61-4892-95fd-a69daca3ef87" contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 14, 2024, HCW Biologics Inc. issued a press release announcing its financial results for the quarter ended June 30, 2024. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The information set forth in this Item 2.02 (including Exhibit 99.1) is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as expressly set forth by specific reference in such a filing.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d)  Exhibits</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:10%;"/>
    <td style="width:2%;"/>
    <td style="width:88%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99.1</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="hcwb-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Press release dated August 14, 2024.</span></a></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6%;"/>
    <td style="width:44%;"/>
    <td style="width:4%;"/>
    <td style="width:46%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">HCW BIOLOGICS INC.</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">August 14, 2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Hing C. Wong</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Hing C. Wong<br/>Founder and Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>hcwb-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:0.69in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img90053791_0.jpg" alt="img90053791_0.jpg" style="width:249px;height:119px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">HCW Biologics Reports Second Quarter 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Financial Results and Business Highlights</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Miramar, FL</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x2013; August 14, 2024 &#x2013; HCW Biologics Inc. (the &#x201c;Company&#x201d; or &#x201c;HCW Biologics&#x201d;) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended June 30, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stated, &#x201c;We reached a critical milestone recently that has profound implications for the future of our Company -- we successfully reached a settlement agreement for an arbitration that created an overhang that hampered our progress for nearly two years. We wasted no time in launching our multi-faceted financing plan, including a significant equity offering and a reinvigorated out-licensing program. We have a bright future ahead, as we have emerged with the TOBI</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">TM</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> platform and a strong portfolio of TOBI</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">TM</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">-based molecules, as well as several development-stage ideas that we consider &#x201c;next generation&#x201d; immunotherapeutics which leverage what we learned from the human data readouts from the initial phases of our clinical trials. We remain committed to developing immunotherapeutic drugs that target the reduction of senescent cells and the proinflammatory factors they secrete. Our focus continues to be on senescence-associated disorders, most typical in age-related diseases, including cancer.  We are also excited to bring HCW9302 to the clinic in the very near future to evaluate this drug in the treatment of autoimmune diseases by expanding regulatory T cells.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Business Highlights</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">On July 13, 2024, the Company entered into a confidential Settlement Agreement and Release (&#x201c;Settlement Agreement&#x201d;) to resolve arbitration brought against the Company and Dr. Hing C. Wong, the Company&#x2019;s Founder and Chief Executive Officer.  The Settlement Agreement includes mutual general releases by and among all the parties.  There were no monetary payments or damages paid by any party under the Settlement Agreement.  See &#x201c;Financial Guidance.&#x201d;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Going forward, the Company retains ownership and control of the TOBI</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">TM</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> platform and TOBI</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">TM</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">-based molecules, with no restrictions under the Settlement Agreement on its ability to use the TOBI</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">TM </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">platform for protein-fusion molecules for non-oncology indications.  The Company may pursue the clinical development of treatments for cancer indications based on HCW9302, HCW9206 and HCW9201. Further, HCW Biologics retains ownership of the Wugen license and shares of Wugen common stock transferred to the Company as the upfront licensing fee from Wugen for granting the Wugen license.   </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">A new financing plan was launched including an equity offering, which the Company intends to close before the end of 2024.  Financing plans also include out-licensing non-core assets, and there are several discussions underway with potential licensing partners.  </font></div></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.69in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"><br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Second Quarter 2024 Financial Results</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Revenues:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> Revenues for the quarter ended June 30, 2023 and 2024 were $622,807 and $618,854, respectively.  Revenues for the six months ended June 30, 2023 and 2024 were $664,690 and $1.7 million, respectively.  Revenues in both periods were derived exclusively from the sale of licensed molecules to the Company&#x2019;s licensee, Wugen.  The licensed molecules are one of the inputs for manufacturing Wugen&#x2019;s products. </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Research and development (R&amp;D) expenses:  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">R&amp;D expenses for the quarter ended June 30, 2023 and 2024 were $1.6 million and $2.0 million, respectively, an increase of $412,520, or 26%. R&amp;D expenses for the six months ended June 30, 2023 and 2024 were $3.9 million and $4.2 million, respectively, an increase of $279,991, or 7%. Manufacturing costs increased in three- and six-month periods ended June 30, 2024 because the Company was replenishing its supply of a high-expressing cell line of HCW9101. Preclinical expenses declined in the three- and six-month periods ended June 30, 2024 due to a change in the types of activities being performed in connection with IND-enabling activities to prepare an IND application to obtain permission from the FDA to evaluate HCW9302 in an autoimmune indication. In the three- and six-month periods ended June 30, 2023, preclinical costs were incurred for setup costs for toxicology studies and other IND-enabling studies.  In the three- and six-month periods ended June 30, 2024, costs were incurred for supplemental research studies. Clinical trial expenses were incurred in the three- and six-month period ended June 30, 2023 related to two clinical studies to evaluate HCW9218 in chemo-refractory / chemo-resistant solid tumors. Clinical trial expenses declined in the three- and six-month periods ended June 30, 2024 because these trials were fully enrolled in the first quarter of 2024.</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">General and administrative (G&amp;A) expenses: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">G&amp;A expenses for the quarter ended June 30, 2023 and 2024 were $1.6 million and $1.6 million, respectively, an increase of $6,332, or 0%. The increase was primarily attributable to an increase in fees for auditing and tax advisory services, offset by a reduction in salaries and benefits arising from the Company&#x2019;s cost-cutting measures.  G&amp;A expenses for the six months ended June 30, 2023 and 2024 were $3.6 million and $3.2 million, a decrease of $436,454, or 12%.  The decrease was a result of cost-cutting measures and a decrease in legal fees incurred in procuring patents and insurance-related costs, partially offset by an increase in financing costs. </font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Legal Expenses:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> Legal expenses for the quarter ended June 30, 2023 and 2024 were $1.4 million and $10.4 million, respectively, an increase of $9.0 million, or 629%.  Legal expenses for the six months ended June 30, 2023 and 2024 were $2.5 million and $14.8 million, an increase of $12.3 million, or 484%. The increase in legal expenses is related to the Altor/NantCell matter. See further discussion of the Altor/NantCell arbitration in &#x201c;Financial Guidance.&#x201d;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Net loss:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> Net loss for the quarter ended June 30, 2023 and 2024 was $4.3 million and $15.3 million, respectively, an increase of $11.0 million, or 255%.  Net loss for the six months ended June 30, 2023 and 2024 was $9.4 million and $22.7 million, respectively, an increase of $13.4 million, or 143%.  </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.69in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Financial Guidance</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">The Company has raised $8.0 million to date in 2024, through a $2.5 million private placement of common stock to officers and directors and $5.5 million issuance of Secured Notes secured by the Company&#x2019;s Wugen shares. The Company is authorized to raise up to $10.0 million in Secured Notes and intends to have the Secured Notes offering fully subscribed.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2024, the Company believes that substantial doubt exists regarding its ability to continue as a going concern for at least 12 months from the issuance date of the condensed interim financial statements, without additional funding or financial support. After considering the elements of the Company&#x2019;s financing plan that were probable to occur within a year of the date of issuance, the Company concluded that substantial doubt was not alleviated in its going concern analysis.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">As reported in the Company&#x2019;s Form 8-K filed on July 18, 2024, as of July 13, 2024, the Company and Dr. Hing C. Wong, the Company&#x2019;s Founder and Chief Executive Officer, entered into the Settlement Agreement, with Altor BioScience, LLC (&#x201c;Altor&#x201d;), NantCell, Inc. (&#x201c;NantCell&#x201d;), and ImmunityBio, Inc. (the parent of Altor and NantCell, together with Altor and NantCell, &#x201c;ImmunityBio&#x201d;), to resolve the previously disclosed arbitration before JAMS brought by Altor and NantCell (the &#x201c;Arbitration&#x201d;) as well as a complaint Altor filed against the Company in the Chancery Court of the State of Delaware for the contribution of legal fees and expenses advanced to Dr. Wong (&#x201c;Complaint&#x201d;).  The parties entered into the Settlement Agreement to avoid the costs, disruption and distraction of further litigation. Under the terms of the Settlement Agreement, no party will make monetary payments to any other party or person and each party will bear its own expenses.  The Company is completing procedures required to be in compliance with the terms of the Settlement Agreement.  The Settlement Agreement provides that, upon completion of these procedures, the parties will stipulate that the Arbitration and Complaint should be dismissed.  The Company retains rights to develop immunotherapeutic treatments based on TOBI</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">TM</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">-based molecules as well as the TOBI</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">TM</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> platform, in addition to the Wugen license and Wugen equity interest. The Company reported a balance of $10.0 million for legal fees incurred but not yet paid that were included within Accounts payable and an accrual of $4.8 million for accrued legal fees within Accrued liabilities and other current liabilities in the accompany condensed balance sheet as of June 30, 2024. In order not to overwhelm the Company&#x2019;s resources, a reasonable payment plan will be required.  The Company is engaged in discussions with the law firms involved with this matter.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">As reported on the Company&#x2019;s Form 8-K filed on August 12, 2024, the Company received written notices from the Listing Qualifications Staff (&#x201c;Staff&#x201d;) of the Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) notifying the Company that it is not in compliance with Nasdaq Listing Rules.  The notifications from Nasdaq do not impact the listing of the Company&#x2019;s common stock at this time.  The Company received a notice that it was not in compliance with Nasdaq Listing Rules for the $50.0 million market value listed securities requirement as of June 17, 2024; the minimum bid price as of August 6, 2024; and the $15.0 million market value of publicly held shares requirement as of August 8, 2024.  The Company has 180 days from the respective date of notice to address each deficiency.  While the Company is exercising diligent efforts to maintain the listing of its common stock on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with the applicable continued listing standards set forth in the Nasdaq Listing Rules.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.69in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">About HCW Biologics:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">HCW Biologics is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions such as long-haul COVID-19. The Company has combined a deep understanding of disease-related immunology with its expertise in advanced protein engineering to develop the TOBI&#153; (Tissue factOr-Based fusIon) discovery platform. The Company uses its TOBI</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">TM </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. The invention of HCW Biologics&#x2019; lead molecules, HCW9218, HCW9302, HCW9206 and HCW9201, was made via the proprietary TOBI&#153; discovery platform. The University of Pittsburgh Medical Center has agreed to include HCW9218 in an Investigator-sponsored Phase 2 clinical trial to evaluate HCW9218 in patients with metastatic, advanced stage ovarian cancer in combination with neoadjuvant chemotherapy (NCT05145569).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Forward Looking Statements:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Statements in this press release contain &#x201c;forward-looking statements&#x201d; that are subject to substantial risks and uncertainties. These statements are made under the &#x201c;safe harbor&#x201d; provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release may be identified by the use of words such as &#x201c;anticipate,&#x201d; &#x201c;expect,&#x201d; &#x201c;believe,&#x201d; &#x201c;will,&#x201d; &#x201c;may,&#x201d; &#x201c;should,&#x201d; &#x201c;estimate,&#x201d; &#x201c;project,&#x201d; &#x201c;outlook,&#x201d; &#x201c;forecast&#x201d; or other similar words and include, the Company&#x2019;s ability to develop new immunotherapeutic treatments for non-oncology or oncology indications; timing of initiation of studies for age-related diseases; the Company&#x2019;s ability to continue as a going concern; the Company&#x2019;s cash runway; the Company&#x2019;s expectations regarding future purchases of licensed molecules by Wugen; the Company&#x2019;s future capital-raising plans and ability to continue with clinical development efforts until they are achieved, if at all; and Company&#x2019;s ability to pay legal fees incurred in connection with the Altor/NantCell arbitration.  Forward-looking statements are based on the Company&#x2019;s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ include, but are not limited to, the risks and uncertainties that are described in the section titled &#x201c;Risk Factors&#x201d; in the annual report on Form 10-K/A filed with the United States Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on May 15, 2024, and in other filings filed from time to time with the SEC. Forward-looking statements contained in this press release are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Company Contact:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Tahoma',sans-serif;min-width:fit-content;">&#xfeff;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Rebecca Byam</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">CFO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">HCW Biologics Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">rebeccabyam@hcwbiologics.com</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.69in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">HCW Biologics Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unaudited Statements of Operations</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Unaudited)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.9%;"></td>
    <td style="width:1%;"></td>
    <td style="width:16.38%;"></td>
    <td style="width:1%;"></td>
    <td style="width:15.46%;"></td>
    <td style="width:2%;"></td>
    <td style="width:15%;"></td>
    <td style="width:1%;"></td>
    <td style="width:14.26%;"></td>
   </tr>
   <tr style="height:24.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="3" style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended<br>June  30,</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="3" style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended<br>June  30,</font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Revenues:</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="3" style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="3" style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Revenues</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$        622,807</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$     618,854</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$     664,690</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$  1,745,566</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cost of revenues</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(502,402)</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(438,443)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(531,752)</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(950,408)</font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total revenues</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;120,405</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;180,411</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;132,938</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;795,158</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating expenses:</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Research and development</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;1,616,666</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;2,029,186</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;3,872,479</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;4,152,470</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">General and administrative</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;1,587,861</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;1,594,193</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;3,596,739</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;3,160,285</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Legal expenses</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;1,426,399</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;10,393,042</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;2,534,811</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;14,812,076</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nonoperating loss</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;&#x2014;</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;1,300,000</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;&#x2014;</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;1,300,000</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total operating expenses</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;4,630,926</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;15,316,421</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;10,004,029</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;23,424,831</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Loss from operations</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(4,510,521)</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(15,136,010)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(9,871,091)</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(22,629,673)</font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interest expense</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(95,514)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(159,666)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(188,951)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(159,666)</font></p></td>
   </tr>
   <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other (expense) income, net</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;301,615</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;15,485</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;684,936</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:#cff0fc;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;41,086</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$  (4,304,420)</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$(15,280,191)</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$  (9,375,106)</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$(22,748,253)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:0.69in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">HCW Biologics Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Balance Sheets</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="range_a1_e33"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"><br></font><font id="range_a1_e32"></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:65.117%;"></td>
    <td style="width:2.004%;"></td>
    <td style="width:15.969%;"></td>
    <td style="width:1.403%;"></td>
    <td style="width:15.508%;"></td>
   </tr>
   <tr style="height:11.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,</font></p></td>
   </tr>
   <tr style="height:11.5pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</font></p></td>
   </tr>
   <tr style="height:11.5pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Unaudited</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">ASSETS</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current assets:</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash and cash equivalents</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$            95,101</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$      1,161,314</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts receivable, net</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;1,535,757</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;654,973</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Prepaid expenses</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;1,042,413</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;404,918</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other current assets</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;230,916</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;164,607</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total current assets</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;6,404,187</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;2,385,812</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Investments</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;1,599,751</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;1,599,751</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Property, plant and equipment, net</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;20,453,184</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;22,806,052</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other assets</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;56,538</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;28,476</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:13.7pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total assets</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;$    28,513,660</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$     26,820,091</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY (DEFICIT)<br>&#160;&#160;&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Liabilities</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current liabilities:</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts payable</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$        6,167,223</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$     16,877,463</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued liabilities and other current liabilities</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;2,580,402</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;6,341,676</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total current liabilities</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;8,747,625</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;23,219,139</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Debt, net</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;6,304,318</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;9,900,721</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total liabilities</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;15,051,943</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;33,119,860</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Commitments and contingencies (Note 8)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stockholders&#x2019; equity (deficit):</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common stock:</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:38.15pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common, $0.0001 par value; 250,000,000 shares authorized<br>&#160;&#160;&#160;and 36,025,104 shares issued at December 31, 2023; 250,000,000 shares <br>&#160;&#160;&#160;authorized and 37,823,394 shares issued at June 30, 2024</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;3,603</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;3,782</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Additional paid-in capital</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;83,990,437</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="text-indent:40pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;86,977,024</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:12.95pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accumulated deficit</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(70,532,323)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(93,280,575)</font></p></td>
   </tr>
   <tr style="height:12.95pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total stockholders&#x2019; equity (deficit)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;13,461,717</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;&#160;(6,299,769)</font></p></td>
   </tr>
   <tr style="height:13.7pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total liabilities and stockholders&#x2019; equity (deficit)</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:80pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$      28,513,660</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-left:0.075in;vertical-align:bottom;border-bottom:2.25pt double;padding-right:0.075in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$     26,820,091</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img90053791_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img90053791_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *-!54# 2(  A$! Q$!_\0
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M/WB?XC\C7<75I;WUL]M=0I-"XPR.,@UY'XP\"3:+OOM/#36'5EZM#]?5??\
M/UKJINE5TDK,\?$PQ>$_>4I.4>SUL>M65_::C;BXL[B.>(_Q1MD?3V-6*^<]
M/U.]TJY%Q8W,D$H[H>OL1T(]C7I_ACXCV^H,EIJX2VN3PLPXC<^_]T_I]*57
M#2CK'5&F$S>G6?+4]U_@=[1117*>N%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C*&4JP!
M4C!![TM% 'CWCSP?_8TQU*P3_0)6PR#_ )8L?_93V].GI7$U](W=K#?6DMK<
M('AE4HZGN#7S_KND2Z'K-S82Y/EM\C$?>4\@_E7I8:MSKE>Z/E<UP2HR]I!>
MZ_P9V'@;QPUF\>E:K+FV8[89V/,9]&/]WW[?3IZM7S17L'PZ\2MJFG-IMT^Z
MZM%&QB>7CZ#\1T_*LL31M[\3JRG'N3]A4?I_E_D=O1117$?0!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %>:_%?3EV6&IJN&R8'/K_ !+_ ":O2JX[XFA3X1);&1<(5^O/
M],UM0=JB.+,8*>%FGVO]QXS6GX>U5]%UVTOE)"HX$@'=#PP_*LRBO5:35F?&
M0FX24H[H^EE8.H92"I&01W%+6'X.O#?^$M-F8Y81>63[J2O]*W*\62Y6T?>T
MYJI!3757"BBBD6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 456O-0M+!-U
MS,J>B]2?H*YZ[\7$DK9V^!_?E_P'^-8U*].G\3$VD=54,UW;V_\ KIXX_9F
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]I4]M+:/Y_\  +%%%%><?4!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"BBBI-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 <WXVF\O0UC'6691^ !/\ 05Y^.M=EX\D^6QB'<NQ_3']:XT5XN-E>
ML_(PG\1(*>*8*>*Y21XIXI@J04#'"I!3!4]M'YMS%'_><+^9J;7T&CT2PB\C
M3[>+^[&H/UQS5BBHYYXK:%YIY$BB099W;  ]S7TL59)(VV1)6=K&NZ=H5MYU
M_<+'G[J#EW^@[_RKBO$7Q-CBWVVAH)'Z&ZD'RC_=7O\ 4_D:\UN[RYO[EKB[
MGDFF;J[G)KLI864M9:(\?%YQ3I^[1]Y_A_P3J?$GQ U#6=]O9[K.S/&%/SN/
M]H]OH/UKCZ**[H0C!6B?-UJ]2M+FJ.["BBBK,@HHHH *55+,%4$L3@ =ZDM;
M6>]N8[:VB:6:0X5$&237KWA#P)!H@2]U )-J'51U6'Z>K>_Y>IRJU8TUJ=F$
MP53$RM';JS,\&> !#Y>IZU$#)]Z*U8<+Z%O?V_/V]'HHKRZE24W=GUV&PU/#
MPY(+_@A1114'0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;?\ [[:C_A:5[_T#;?\ [[:N!HHY4',SOO\ A:5[_P! VW_[[:C_ (6E>_\
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M_6MRN"MBG+2&Q])@LHC3M.MJ^W1?YB*H50J@!0, #M2T45R'MA1110 4444
M%%%% ')_$;_D4Y/^NR?SKQZO8?B-_P BG)_UV3^=>/5<=C.6X44450@HHHH
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M?FD B'_ B ?TS70UP/Q1N]FG6%F#_K)6D(_W1C_V:FMQ/8\PHHHK0S"BBB@
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M6FOGU"BBBLSI"BBB@ HHHH **** "BBB@#D_B-_R*<G_ %V3^=>/5[#\1O\
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M\6VS$96!6F;\!@?J17,UZ-\+;/G4+TC^["I_4_\ LM)[#6YZ/11169H%%%%
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M,G]<U[97F7Q2L]MY87H'WXVB8_[IR/\ T(_E51W)EL>?T4459 4444 %%%%
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M4^=J*^C%14&%4*/0#%+1S!RGSE3DC>3.Q&;'7 S7T711S!RGSM]GG_YXR?\
M?)H^SS_\\9/^^37T311S!RGSPMK<.V%MY6/H$)I_]GWO_/G<?]^F_P *^A**
M.8.4^>_[/O?^?.X_[]-_A0-.OB<"SN"3_P!,F_PKZ$HI<P<I\_\ ]C:I_P!
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M]!D\K6+<YX8E3^(KNJ\ZLY/)O()/[DBM^M>BUZN62O"4?,TB%%%%>F4%%%%
M!1110 4444 %%%% !1110 4444 <G\1O^13D_P"NR?SKQZO8?B-_R*<G_79/
MYUX]5QV,Y;A1115""BBB@ HHHH NZ-_R'-/_ .OF/_T(5] 5\_Z-_P AS3_^
MOF/_ -"%?0%1(N(4445)04444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !6+XO_P"12U+_ *XG^8K:K%\7_P#(I:E_UQ/\Q36X,\,HHHK0R"BBB@ H
MHHH **** /H33_\ D&6O_7%/Y"K-5M/_ .09:_\ 7%/Y"K-9&H4444 %%%%
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M%?0%?/\ HW_(<T__ *^8_P#T(5] 5$BXA1114E!1110 4444 %%%% !1110
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M'Y5YE7MO@JS^Q>$K%2,-*IF/ON.1^F*4MAQW.@HHHK,T"BBB@ KGO&6OC0-
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M\\2_]!+_ ,@1_P#Q-<Y118+G1_\ ">>)?^@E_P"0(_\ XFC_ (3SQ+_T$O\
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M)H_X3SQ+_P!!+_R!'_\ $USE%59$W9T?_">>)?\ H)?^0(__ (FC_A//$O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH \Q^*-GLU"QO0.)(VB;ZJ<C_ -"_2N KV#XC6?VGPLTP'S6TJR?@?E/_
M *$/RKQ^M([&<MPHHHIB"BBB@ HHHH <CM'(KH<,I!!]#7T)97*WEA;W2_=F
MB60?B,U\\U[1X"O/MGA*U!.6@+0M^!R/T(J9%1.EHHHJ"P/2OG>Y22.ZF24D
MR*[!R?7/-?1%>&^+[7['XLU&/& TOF#_ ($-W]:J),C$HHHJR HHHH ****
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M_P#/G<?]^F_PH K459_L^]_Y\[C_ +]-_A37LKN-"[VLRJ.I:,@"@""BBB@
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M'JN.QG+<****H04444 %%%% %W1O^0YI_P#U\Q_^A"OH"OG_ $;_ )#FG_\
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MC[5RE%#!:'T;17+>"/$8UO2A!.^;VV 63/5U[-_0^_UKJ:R9J%%%% !1110
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MH **** .3^(W_(IR?]=D_G7CU>P_$;_D4Y/^NR?SKQZKCL9RW"BBBJ$%%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "L7Q?\ \BEJ7_7$_P Q6U6+XO\
M^12U+_KB?YBFMP9X91116AD%%%% !1110 4444 ?0FG_ /(,M?\ KBG\A5FJ
MVG_\@RU_ZXI_(59K(U"BBB@ HHHH Y'Q_H/]JZ-]KA3-U9@N,=63^(?U_ ^M
M>05]&UXQXV\.G0]7,D"8LKDEHL=%/=?P[>U7%]")+J<S1115$A1110 4444
M%%%% &CHVMWNA7HN;.3&>'C;E7'H17KWAWQ98>(8@L;>3=@9>W<\_5?45XA3
MDD>*19(W9'4Y5E."#Z@TFKC3L?1=%>7:#\2+BV"P:NAN(N@G3 <?4=&_0_6O
M1--U?3]7A\VQNHYE'4*?F7Z@\BH:L6G<NT444AA1110 4444 %%%% !1110
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MIPRG(/H:.4.8^BZ*@LKE;RPM[I?NS1+(,>XS4]06%%%% !7AGBVS^P^*M1A
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M1PI]YVP*] CC6*)(T&%10H^@KORJE>;J/IH6AU%%%>Z4%%%% !1110 4444
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MZC_6>Z^_MW^O7S%E*L58$$'!![5HG<S:L)1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110![
M3X$O/M?A&TR<M#NB;\#Q^A%=)7GOPMN\VVH61/W7651]1@_R%>A5F]S1;!11
M12&%<5\3+/SO#\%R!S!.,^RL"/Y[:[6LCQ1:?;O#&HP 9)A+J/4K\P_44UN)
M['A-%%%:&84444 %%%% !6EX?NOL7B'3[@G"I.FX_P"R3@_H36;1G!R* /HV
MBJNFW0O=+M+H'/G0I)^8!JU61J%<E\1K7[1X4:4#FWF23\#\O_LU=;6;XAM?
MMOAW4+?&6:!]H_V@,C]0*:W$]CP2O?="L_L&@V-J1AHX%##_ &L9/ZYKQ#1;
M/[?K=C:D966=%;_=SS^F:]_JI$Q"BBBH+"BBB@ HHHH **** &2QK-"\3C*.
MI5A[&OGJY@:UNIK=_OQ.R-]0<5]$5XGXWL_L?BV] 'RRL)5]]PR?US51)D<]
M1115D!1110 4444 6M-NC8ZI:78./)F23\B#7T&"",@Y!KYRKWOP]=?;?#NG
MW&<LT";C_M 8/Z@U,BHFE1114%G-^/+3[5X1NR!EH2LH_ \_H37BU?0FHVHO
M=,NK4C/G0O'^8(KY[((.",$5<2)%_1;/^T-;LK0C*RS*K#_9SS^F:]^KR'X<
M6?VCQ0)R/EMH6?/N?E'\S^5>O4I;CCL%%%%24%%%% !1110 4444 %%%% !1
M110 4444 <AXV\/F]M_[2MDS<0K^\4?QIZ_4?RKSD5[K7FWB_P -'3IC?VB?
MZ)(?G4?\LV/]#_GM7DX_"_\ +V'S_P S*<>J.:MKB:UG2:"1HY4.593@BN\T
M7QQ%,%@U0"*3H)U'RGZCM_+Z5Y^*>*X:%>=)WBR(R:V/;(I8YXQ)%(LB-R&4
MY!I]>.66H7E@^ZUN9(B>H5N#]1T-;UOXWU6-0)%MYO=D(/Z$#]*]2GF$'\2L
M:*HNIZ+17 MXXU%EPMO;*?7#'^M9EYKNI7X*SW3[#_ GRC].OXU<L?36VH_:
M(['6?%%O8JT-HRS7/3(Y5/KZGVKAI)9)YFEE<O(YRS'N:A%2+7GUJ\JKNS-R
M;'BGBF"GBN=B'K4@J,5(*EC'"GBF"M/2--?4;G!R(5Y=OZ?6HC"4Y*,=V6C6
M\-:?@&]D7K\L>?U/]/SKHZ:B+&BHBA548 '84ZOI,/15&FH(T04445L 4444
M %%%% !1110 4444 %%%% !1110!R?Q&_P"13D_Z[)_.O'J]A^(W_(IR?]=D
M_G7CU7'8SEN%%%%4(**** "BBB@"[HW_ "'-/_Z^8_\ T(5] 5\_Z-_R'-/_
M .OF/_T(5] 5$BXA1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %8OB_P#Y%+4O^N)_F*VJQ?%__(I:E_UQ/\Q36X,\,HHHK0R"BBB@ HHH
MH **** /H33_ /D&6O\ UQ3^0JS5;3_^09:_]<4_D*LUD:A1110 4444 %%%
M% !1110 5R/BKP1;ZUNN[+9!?]3V67Z^A]_SKKJ*$[ U<^>;RSN=/NGMKN%X
M9D.&1A4%>\ZUH&GZ];>3>198?<E7AT^A_ITKRGQ!X-U+0F:7;]ILQTGC'W1_
MM#M_+WK12N9N-CG****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** .L^'5W]F\5)$3@7$3Q_B/F'_H
M->PUX!HMW]@UNRNB<+%.C-_NYY_3->_U$BX[!1114E!2,H92K $$8(-+10!\
M]ZA:FQU*ZM&ZPRM'^1(JM73>/K/[)XMN6 PLZK*OXC!_4&N9K5&3"BBB@ HH
MHH **** /:? =U]J\(VF3EH2T1_ G'Z$5TE<!\+;K=8:A:$_ZN59!_P(8_\
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MP0C#2)YI]]QR/T(K>I/<:V"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
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M_*N.67R7PR(]F>9BGBO0_P#A%]&_Y\__ "*_^-3QZ%I<1^6QB/\ O#=_.I6
MJ=6@]FSSN&*29@D4;NWHHR:W++PO?W&#,%MT]7Y/Y#^N*[:.*.)=L:*B^BC
MI];PP$5\3N4H&9I^A66GX94\R4?\M'Y(^@[5IT45VPA&"M%6+M8****H HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** .3^(W_(IR?]=D_G7CU?0U
MW9VU_ 8+N".:(D'9(N1FJ'_",:%_T";/_OT*I.Q+C<\(HKW?_A&-"_Z!-G_W
MZ%'_  C&A?\ 0)L_^_0I\PN4\(HKW?\ X1C0O^@39_\ ?H4?\(QH7_0)L_\
MOT*.8.4\(HKW?_A&-"_Z!-G_ -^A1_PC&A?] FS_ ._0HY@Y3Q71O^0YI_\
MU\Q_^A"OH"LN/PWHL4BR1Z7:*Z$,K"(9!'0UJ5+=RDK!1112&%%%% !1110
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M+E1Y%)\-==3.UK23_=E/]0*A?X>>(5QBWA;Z3+_6O8Z*?,Q<J/&O^%?>(_\
MGTC_ ._R_P"-'_"OO$?_ #Z1_P#?Y?\ &O9:*.9ARH\:_P"%?>(_^?2/_O\
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M"M2U7Q!+?6"1&.5%+;GVG<!C^0%8?_"NO$'_ #SM_P#OZ*]AHJN9D\J/'O\
MA77B#_GG;_\ ?T4?\*Z\0?\ /.W_ ._HKV&BCF8<J/'O^%=>(/\ GG;_ /?T
M4?\ "NO$'_/.W_[^BO8:*.9ARH\>_P"%=>(/^>=O_P!_11_PKKQ!_P \[?\
M[^BO8:*.9ARHKV"S)IULEP )UB428.?FP,\_6K%%%24%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 453O\ 5;'2UC:]N%A$A(7()SCZ51_X2W0O^@@G_?+?X5G*K3B[
M.27S%=&U15:QO[74K?S[282Q;BNX CG\:LU:::NAA1113 **** "BBB@ HHH
MH **** "BBB@ HK%\2:ZV@V<4ZP"8R2;,%MN."?3VKFO^%CS?] U/^_Q_P *
MYZF*I4Y<LGJ2YI:,[^BJNFW9O]-MKLH$,T8?:#G&15JMTTU=%!1113 ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJK?ZC
M::9 LUY,(HV;8&()YP3CCZ&L_P#X2W0O^@@G_?+?X5$JL(NTFD*Z-JBJEAJE
MEJB.]E.)E0X8@$8/XU;JDU)70PHHHI@%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*<@7D(^?'&\?WA_7_P"O7IX3&^U?)/1FD)WT9T-%%%>@:'#_ !'_ ./?3_\
M??\ D*X"O6?$OAY]?CMU6Y6'R2QY3=G./?VKGO\ A7$W_023_OR?\:\;%X6K
M4K.45H8SBV[HUO '_(NM_P!=V_D*ZFLGP]H[:'IIM&F$Q,A?<%QU _PK6KT\
M/%PI1C+<UBK(****V&%%%% !1110 4444 %%%% !1110!Q_Q$_Y!%K_UW_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O-?B%_P A^#_KU7_T)Z]*KS7X
MA?\ (?@_Z]5_]">N',/X'S(J?"<E7N]>$5[O7/E?V_E^I-+J%%%%>L:A1110
M 445SGB/Q7;:3"\%LZRWQ& HY$?NW^%14J1IQYI,3:6YR'CF[6Z\1LB'(@C6
M(X]>2?YX_"L&SMFO+V"V3.Z614&/<XJ*21Y9&DD8L[DLS'J2>]=IX$T-WG_M
M:="(TRL /\1Z%OH.G_ZJ^?C%XFOZO\#!>](]  "@ # ' I:**^C.@Y+XA?\
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M_80"K'6NM97IK+\"_9>9X14MO<SVDRS6\KQ2+T9&P:]>O_#NE:BI$]E&'/\
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MWAW^M=ZCI)&KHP9&&593D$>M>%5Z5X$M]1ATUWN7(M'Y@C<<^Y'H#Z?C]>K
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLBKKD\9ZO;G'X,*\#"?QXW.>'Q(]*HHHKZ0Z0HHHH **** "O(?%<(@\47Z
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M[Z9\_P#]E%><UVOP[O0EW=V3'_6J)$^HX/\ /]*Y,#)*NKD0^(]"HHHKZ$Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1SWC?_D5KC_?3_T(5Y37JWC?_D5KC_?3_P!"%>4UY69?QEZ?YF53<]2\"?\
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M;&5V7@SPTUU.FJ7B8MXSF%"/OL._T'\ZL^'_  ,VY+K5P !RML#G/^\?Z?\
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M(8C^^/\ >?T^@_G]*P=(\07^BO\ Z-+F(G+0ORI_P/TKTK6_#5CK:;I5\JX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5F:CX?TO5;A9[VU\V1
M5V!O,9>,DXX(]36G14RC&2M)7!JY@_\ "&:!_P ^'_D:3_XJC_A#- _Y\/\
MR-)_\56]16?U>E_*ON0N5=C!_P"$,T#_ )\/_(TG_P 51_PAF@?\^'_D:3_X
MJMZBCZO2_E7W(.5=C!_X0S0/^?#_ ,C2?_%4?\(9H'_/A_Y&D_\ BJWJ*/J]
M+^5?<@Y5V,6/PEH41^73T/\ O.S?S-:-MI]E9_\ 'M:00GUCC"G]*LT5<:4(
M_"D@LD%%%%6,**** *FHZ99ZK;K!>P^;&K;PNXKS@C/!'J:S/^$,T#_GP_\
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M"P=!?9%R1[%>SL+33XO*M+>.%.X1<9^I[U8HHKH225D4%%%%, HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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(H **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>hcwb-20240814.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-08-14T12:28:41.2524+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://hcwbiologics.com/20240814" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:hcwb="http://hcwbiologics.com/20240814" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hcwb-20240814.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information, Former Legal or Registered Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="10150.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140115676791664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 14, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 14,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HCW Biologics Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001828673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-5024477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2929 N. Commerce Parkway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Miramar<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">842-2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not Applicable<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HCWB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @  X4.63JJHN=
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    "  #A0Y9!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  .%#EGWR:M.[@
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    (  .%#EF97)PC$ 8  )PG   3              "  <P!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @  X4.65+7G:"8!   Z!$  !@
M             ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    (  .%#EF?H!OPL0(  .(,   -              "  =L,  !X;"]S
M='EL97,N>&UL4$L! A0#%     @  X4.69>*NQS     $P(   L
M     ( !MP\  %]R96QS+RYR96QS4$L! A0#%     @  X4.63JJHN=  0
M/ (   \              ( !H!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   (  .%#EDD'INBK0   /@!   :              "  0T2  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  .%#EEED'F2&0$  ,\#
M   3              "  ?(2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(  #P4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hcwb-20240814.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="hcwb-20240814.htm">hcwb-20240814.htm</File>
    <File>hcwb-20240814.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "hcwb-20240814.htm": {
   "nsprefix": "hcwb",
   "nsuri": "http://hcwbiologics.com/20240814",
   "dts": {
    "inline": {
     "local": [
      "hcwb-20240814.htm"
     ]
    },
    "schema": {
     "local": [
      "hcwb-20240814.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_b77fe613-4ec7-4762-9740-c5a8c1fe941d",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hcwb-20240814.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b77fe613-4ec7-4762-9740-c5a8c1fe941d",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hcwb-20240814.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://hcwbiologics.com/20240814/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-24-097108-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-097108-xbrl.zip
M4$L#!!0    (  .%#EEU(5+;^A(  &Z:   1    :&-W8BTR,#(T,#@Q-"YH
M=&WM/6M3XSBVW^=7:.F[,U 7)9;?#M!;3(#N['0#!4S-U/TR)5LRT;9C9_R
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MR+ANT "'NCSHP'=M[(4VP08EH142:G/'6I9TK=UWM:)_)Q BM>5S-P8LM/7
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M+3"JY%IH2&Q(/+2L0Z2W\@ (3'!+ZM,2.Q8OI,1O_Y0! 5F;BI27\4)" DS
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MF2_E#T\DOKH_.!/\(X&+_P%02P,$%     @  X4.6?6#:E&G)0  WRP"  \
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MI;(3 B"<-ASP(>#RTA9)4C"%6 #_8V-\AF9#"E*F23[#2)61A&0$BR;7AL^
MH\E4-!WP!I,R ?O$&#$J+@:K-4G !,QF4S5/F-AJ6V<NN4!@!1PT"-*"H:")
M9$+X52 ,+09*@H'ZZ/N.AQ_@1#0AL7G\#59JIL1K(:S@*7[!HAPZA0>$5#0K
MGLY0="OA#I3"4*$B,2\'A]8<OP)]H8:7\E$>:6I]U=1L%N#9H6!Y*J;%'DUT
MPY[=[=X\QK"#")CPYV<PI@DH<YDUN+9@U+A '90Q0@ W**/9T3#B5U5J=6!X
M9N)%Y^H9E*II=JPHT\#FY1'*96 [?HV&\RFTFFV_^V*'Z#$#*&8K8AQP0TWZ
MAED:%];S2I:N[ _HAEW'66YV-QSQ.097#LQ(U]>N'%4RK3!P51 &Y*:(000R
ME-]#4(.Q4D7G<_OVI+1O43-\ =# VI*7A;)<]>3<]8:6P:9-(C02*V;Q($UR
MM!?9"-29S!:&A;U<]Q(J3^C6^\=RT748"SXD[Z_ $,@$=/=Y"/:MTA5?X=65
M\]%Z!2@Y 4T D]8J'UWHJ!3NRAB;H"7&P*I0>A%0 .Z];ACTQR7^ S8Y/,0!
M(3-X8(;-2XQ,A&P".@T<$"9"W=Q,-3 C>N39FK%!Z^=\'O.8!_'^EHL0E> U
MQ:+V8.8[,9;AGR+#_RU!I@$OXI*EX2*W@[F&O$:22P"Y'(NI@C:^FB816C?6
M*[O5*[/DN=7_4@Y^K*0^^"V!#K3<+.O04\!0)!N("",1H#-RR>N,1[([BI=X
MQ"@1N&@9AP>'8/\!$<MET"&D)&XD,8YJ- -5%Q9A+Z,1"[DP8:"1\E3FO.(L
M+7K-2CH4CI!N7#MBU6:)A@(,P[A?5/W@.1W%.OIGMTD^Y"DZJ'0ISG]=/!F1
M]$<.:IGHX!-73<DQN'[*3=;?H3>,SF:6!-]@G"R60YZFVB%<,"R4[TKR*3C>
M,*EY/&L(FE8YX[H]G-\(FBGC\PM# /(1JW.MSBTY\H3$\,QBM!5#M28XJPSL
M,O(:+X=;J0DA58$JL.E0Q5&"* '4#SA@4O,G?('(5QLSA'Q8Z%7J>(@Q:Y>"
MMB@. FP%\,DSC)3I.$^J(REEL$S(()=R+K8O03XHH3Y-,N,<5"+!L%C(K\VU
M/%$ZX0:CF,*B0.&_6,Y%6F*"0PA!5"3"%&-;<1+RXO%G"Z!6X ]%RI7*/(+A
MYI/X>$%(%,EGQ:R7\\]<^'4E3P%F=I.5]AC[_#^=0MN#5/Q$)2"^(8&+AFO7
MHYJ<5;O\NP?-;$T2WISQQND\:1&0-P#]_:W!AK >1RP"II8VN[%.V8VKIKBC
M:.*;0:K_/L#(W?"0MI[C5J/E>+IA[159?.1:.IL-=!^$#;YAZ'P!<Q;W(H]V
M&#HJQE#FF:Q/LO*5-:X KL+)SSN>1WM.5WW\O./V:*_=HAA4F:*!")[Y#$SN
M:QU(<85AZ&PL[]1'IT4[?4?WX3:[F$$3@?&YOA\1$\ WN )@FB2AU.V #0 /
MAK@-&^52O3/?VI8L4HDUQGFNA(J6O/-Y4-\\RJGVNTVX8D4#Z+9@NH\)%(AX
MFIOH!"Q+CMO5N=H.5LW,VY^F">Y^@\]BW7@K0FX2(9*S%%SS2K*GBH:]_/(C
MFTR/W[W"G7\$I3PB.XP(FM&4@[F/N'&;G8+[M3CPFLYJ<8!Q XPPI&H7$%CO
M><OU:-N#AJ%;K_.B2=8.Z/O$D]_L+XZIU?3N.B:OVZ?]OJO&U(4A_;H@$()$
M9K)\(=2Y'BGG#1U>%%<--<I2S*U(BB4#'K B2EW$;3#HD_)IQ&,A55*>2K#-
MI]-HIM)'5/YM \B":7YJ()BIA) W28]]%R.DOZ6\C,*6- S59\5@^?</.,Q5
MJ@LC >8?\K*=V53'4AD24^#.)LQ-Q79XBH%FW27 +=:A"1T,.OOTKL%C-HA4
M5&O^*O0 LYNJW)P8GR(@+HN,2_PV&6"<%QN?"!5FFNN*#^].%I)QBC0>S N*
MJ\DW\ZASDYS=BQP^Q6&65-: 4+ #5.0J>(R@E3S+I^9;!>+D2IB NLSR$">,
M/:J,JT62F*]!>=UO@*#LUPX* :64D<[VUD*J[/!T(6UL#J#%AFY'T4H6+7*S
M4'=?)O/-@H(:R\OGN3V%GC&?)(V4#U.50S8CK\N/)"A7S$*5222@W7R2I#=,
MXL%<4&%;_%=EUFG2Z Q?'J=)%,T[&(I49J4D+0*OUG"PAL,-F_ FC42ECH3P
M%,  \UXN.'GY-Z4;3ZJFP^XL!S.8S5H.E0]NT](=ZON>TM$.Z.BORH8W7U^J
MI'T!P(8)$98!IP[R#(2K5F*5AH!1A]R,G8$4RHH<]HQ= ?DO,-D4\U73"_ @
M),6-%Q#K*A>GD@<+K8"K KT9D3Z -1RJ3>E4Z#W"0DM=\U=03C>"/%,=3V!,
M>:H$_UKJ?J\9M$1@OVH&,12)%5O,[] 6>HK0E>N],+Y3^0A2E9D30OC\RJ&;
M_//R)3QFP$> 9T7FJ@8!3RK0%M6496IK&%\5,32#V\-E)J_29%0G3K%(&4/E
M&BRM9+F?I=ZQ+IJ5M#<)L(\*E^\+4;K#6(\>R<,$:6M)D#KS3VZ3I/VJNP9]
M=[P^,O^:47V? /*:[:6!M9J]B@1:&HKK-?V%L;1ZK67I7HJ4<FA"+MB6\/!)
M!);BZT]@&YZBES0!'8#9G)@5.=0I))6]ZB(&M/12->44^K39E%;>/(C-/X'2
MBA*Y4TE3C.$[90QH_N>M.6<:3FY7>?5F$>.Z2S+&:[=1QEP;SYVE"PZIORSU
M/&]=('K%D/RJA$23I^6_6)^*8I,Q=IN,X=ED#)N,L1?)&+7*(:O]1 ]_GH]6
MDJ>P/_>'%$\,V_>=:#7#'@M0I$S@3M/SWMR(4F>W,5 .GDEQ.$\=BR-LT>F:
MIN("GP/C(^!%/OYBTCM6!U#'W70(1ILNB?GM>;O2F) R1\1A&^<\R#&4\RG)
MN*H$HWX;S%;'N706O$Z^;RX<(0#GC>79.$F!9,I_4[,E^11_1C]V/F>8ZV*O
M.F)4YCNK8A'ZH$CUJ;(XA8[2RWP@@U0,>-A\*H!Z,IQSHG8CE_;"JKNL _",
M^04W50T0"KB!A-(T3/)!1OB5P(VSE(]8&A:[L)6S146= J*"H:-$1QOQ.(L^
M^@&-XO'/C+A>X<?,*S44W*,8UP0=,$E-YZ8@D%,QJ51C4J5KU+$9?30JR3."
MAAWZ%1A2S77A .BV\DX^Q:H?37*"!F)9GJ(XC6+"#K+H_AJC+AU%,&4N4E71
M85"$T), ^$L-";=759&9HL%B;L5D%\F/I,+C!>$Z^J-?%R<9GI?E%[KB@] '
MO!9IS8  ,RGD+NM+[1M3W=>.WKN)/D!ZE#71S!;NBE/CZ83T&O\$1HGTB35]
M2+Y72!MF1-#:D_.;/:).%T_BKSLF:<Y6JA G'IP[#P17W/GQX^G\.+[ZNCQ_
M3TD1"Z6FDE[Q7/%YY5$<XAEF6("@A/9II?8>)G1HNT-WCX_.6\Z2$5<!V<H
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M2P$"% ,4    "  #A0Y9OJ9ZLMD(  "(90  $0              @ $I$P
M:&-W8BTR,#(T,#@Q-"YX<V102P$"% ,4    "  #A0Y9]8-J4:<E  #?+ (
M#P              @ $Q'   :&-W8BUE>#DY7S$N:'1M4$L%!@     #  ,
*NP    5"      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>hcwb-20240814_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hcwb-20240814.xsd" xlink:type="simple"/>
    <context id="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001828673</identifier>
        </entity>
        <period>
            <startDate>2024-08-14</startDate>
            <endDate>2024-08-14</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_f4f147cd-fe09-42a0-9093-fe59ada1fe2d">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_4b031ab4-97cb-4beb-9515-5f9db386250e">0001828673</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_bd02c29f-ee1b-4440-b149-6ed98b85a7f3">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_f14da008-21d3-4f23-8ab9-7aa1975fdcf0">2024-08-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_8c4f915f-5240-4751-a751-7e317eef37ab">HCW Biologics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_335add76-7590-4243-86b5-0083d73165e1">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_bbd41bde-d871-41ff-95c3-5c112780d1a0">001-40591</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_d789c665-7eff-4a51-93ce-545bce87df43">82-5024477</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_59f4c9ec-684b-428c-9579-40c21be17d01">2929 N. Commerce Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_84ca2f67-6a13-4fb5-b106-08e6fa408061">Miramar</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_d905d941-916a-45b3-8d88-ce81a78f120a">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_24285dc6-ee82-410c-9340-49aaf645da18">33025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_f9c4f0d2-6efa-4401-a6ac-75bc9bd0b25a">954</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_e84430c1-7605-468d-9e1e-42d6da1d5236">842-2024</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_9338418e-7a1f-4c30-8725-70067f97b57d">Not Applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_f5a46b62-1ec3-45a2-8154-47bf5db44ecd">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_58c30669-9222-4d4b-83e3-93ba210e94e3">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_157e875f-a13a-47c4-8947-ff3fa58ac824">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_552b8d6d-df76-40b8-8b49-af0412ec6d83">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_48a7d99d-7bcd-4f05-ae94-5847a99c1399">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_e2cd2054-4337-4b2b-8afd-712f88af8534">HCWB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_0fde23ac-f201-4b86-9f61-3a1f5f1a6e75">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_9bfbc21a-c294-4387-bc36-073a2423c1b9">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_b77fe613-4ec7-4762-9740-c5a8c1fe941d"
      id="F_cfe9e9cf-ba61-4892-95fd-a69daca3ef87">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
